DermiPsor Ltd. engages in the research and marketing of therapeutic agents. It offers DPS-101, a synergistic combination therapy for topical treatment of plaque psoriasis; and DPS-102, a non-steroidal treatment for scalp psoriasis. DermiPsor Ltd. was founded in 2004 and is based in Rehovot, Israel.
nextgen biomed ltd (NXGN:Tel Aviv)
27 Aharoni Street
Phone: 972 5 252 87768
Fax: 972 8 946 8290--
|No competitor information is available for NXGN.|
|View Industry Companies|
|No financial data is available for NXGN.|
Sponsored Financial Commentaries
To contact NEXTGEN BIOMED LTD, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.